Cell MedX Corp. (CMXC)

USD 0.43

(N/A%)

Operating Income Summary of Cell MedX Corp.

  • Cell MedX Corp.'s latest annual operating income in 2024 was -313.43 Thousand USD , up 29.63% from previous year.
  • Cell MedX Corp.'s latest quarterly operating income in 2024 FY was -268.35 Thousand USD , up 39.75% from previous quarter.
  • Cell MedX Corp. reported an annual operating income of -445.37 Thousand USD in 2023, up 33.69% from previous year.
  • Cell MedX Corp. reported an annual operating income of -671.69 Thousand USD in 2022, down -38.11% from previous year.
  • Cell MedX Corp. reported a quarterly operating income of -76.95 Thousand USD for 2024 Q1, down -18.8% from previous quarter.
  • Cell MedX Corp. reported a quarterly operating income of -42.56 Thousand USD for 2024 Q2, up 44.69% from previous quarter.

Annual Operating Income Chart of Cell MedX Corp. (2024 - 2011)

Historical Annual Operating Income of Cell MedX Corp. (2024 - 2011)

Year Operating Income Operating Income Growth
2024 -313.43 Thousand USD 29.63%
2023 -445.37 Thousand USD 33.69%
2022 -671.69 Thousand USD -38.11%
2021 -486.35 Thousand USD 53.16%
2020 -1.03 Million USD -16.77%
2019 -889.26 Thousand USD 42.09%
2018 -1.53 Million USD -28.24%
2017 -1.19 Million USD 43.01%
2016 -2.1 Million USD -103.58%
2015 -1.03 Million USD -5471.14%
2014 -18.52 Thousand USD -46.62%
2013 -12.63 Thousand USD 20.32%
2012 -15.85 Thousand USD 0.0%
2011 - USD 0.0%

Peer Operating Income Comparison of Cell MedX Corp.

Name Operating Income Operating Income Difference
Acutus Medical, Inc. -14.36 Million USD 97.817%
Biotricity, Inc. -8.82 Million USD 96.45%
Dynatronics Corporation -2.27 Million USD 86.211%
Nemaura Medical Inc. -9.59 Million USD 96.733%
PetVivo Holdings, Inc. -10.62 Million USD 97.049%
RetinalGenix Technologies Inc. -2.08 Million USD 84.982%
Sonendo, Inc. -57.74 Million USD 99.457%
Telesis Bio, Inc. -35.15 Million USD 99.108%
Talis Biomedical Corporation -66.81 Million USD 99.531%
Viveve Medical, Inc. -21.55 Million USD 98.546%